Trial Profile
An Open-label, Multi-center, Non-interventional Study to Investigate Clinical Usefulness of Hydromorphone OROS in Korean Cancer Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2016
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Janssen
- 17 Jan 2011 New trial record